Clinical Trials Directory

Trials / Completed

CompletedNCT02111538

Body Composition in Systemic Amyloidosis

Prognostic Value of Phase Angle in Systemic Immunoglobulin Light-chain (AL) Amyloidosis

Status
Completed
Phase
Study type
Observational
Enrollment
127 (actual)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Malnutrition is a prominent clinical feature of patients affected by systemic immunoglobulin light-chain amyloidosis (AL), with a prevalence ranging between 25-50%. Although the prognosis predominantly depend on the presence and severity of cardiac involvement, it was shown that malnutrition is an independent predictor of survival and quality of life. However, the assessment of nutritional status by common indices based on anthropometry is not always feasible and accurate due to reduced performance status and/or the presence of fluid imbalances (for example edema and ascites). Several recent studies have demonstrated the prognostic value of the phase angle. Moreover, the value is supported by its applicability to patients who are bedridden or present alterations in the state of hydration.

Conditions

Interventions

TypeNameDescription
OTHERDietary adviceStandard dietary advice are provided to all patients at baseline and during the follow-up to all requiring or asking for

Timeline

Start date
2014-02-01
Primary completion
2019-04-01
Completion
2019-04-01
First posted
2014-04-11
Last updated
2025-05-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02111538. Inclusion in this directory is not an endorsement.

Body Composition in Systemic Amyloidosis (NCT02111538) · Clinical Trials Directory